studi
describ
webbas
resourc
develop
assist
scientif
commun
design
effect
therapeut
ebola
viru
firstli
predict
identifi
experiment
valid
epitop
antigensprotein
five
known
ebolavirus
secondli
gener
possibl
overlap
peptid
protein
ebolavirus
thirdli
conserv
peptid
across
five
ebolavirus
four
human
pathogen
speci
ident
sequenc
human
proteom
base
genom
project
identifi
final
identifi
peptid
epitopebas
vaccin
candid
could
activ
band
tcell
arm
immun
system
addit
also
identifi
efficaci
sirna
mrna
transcriptom
absent
human
transcriptom
five
ebolavirus
observ
three
speci
potenti
target
singl
sirna
sirna
potenti
target
least
two
speci
web
server
ebolavcr
develop
incorpor
inform
use
comput
tool
http
crddosddnetoscaddebola
ebola
viru
ebov
came
pictur
outbreak
sudan
subsequ
zair
initi
detect
near
ebola
river
zair
speci
receiv
current
name
infect
anim
human
medium
transmiss
viru
mainli
bodi
fluid
milk
saliva
semen
urin
etc
ebola
viru
diseas
evd
character
abrupt
fever
stomach
pain
headach
vomit
diarrhea
evd
overlap
symptom
diseas
malaria
flu
typhoid
make
complic
diagnos
infect
symptom
onset
diseas
confirm
use
elisa
pcr
viru
isol
test
diseas
diagnos
next
challeng
treatment
tackl
symptom
provid
intraven
fluid
maintain
electrolyt
oxygen
statu
blood
pressur
even
limit
option
treat
diseas
directli
recent
zmapp
invent
ebola
viru
ebov
combin
monoclon
antibodi
although
test
human
success
anim
studi
carri
best
author
knowledg
known
approv
vaccin
diseas
avail
moment
howev
two
promis
vaccin
candid
current
phasei
clinic
trial
first
candid
develop
glaxosmithklin
gsk
nation
institut
allergi
infecti
diseas
niaid
vaccin
compris
glycoprotein
gene
ebov
sudan
ebola
viru
sudv
control
chimpanze
adenoviru
second
potenti
vaccin
rvsvzebov
develop
newlink
genet
merck
vaccin
usa
collabor
public
health
agenc
canada
use
attenu
viru
glycoprotein
ebov
rvsvzebov
found
safe
effect
clinic
trial
result
past
rnai
proven
promis
tool
treatment
mani
viral
diseas
help
circumv
viral
infect
sirna
target
zair
ebola
viru
rna
polymeras
l
protein
formul
stabl
nucleic
acidlipid
particl
snalp
show
complet
protect
guinea
pig
separ
studi
author
use
combin
sirna
target
l
formul
snalp
observ
protect
twothird
rhesu
monkey
macaqu
given
seven
post
exposur
treatment
set
small
rna
molecul
encapsul
lipid
nanoparticl
target
vital
viral
protein
l
cleav
viral
rna
cell
prevent
multipl
recent
studi
show
short
interf
rna
sirna
packag
lipid
nanoparticl
abl
protect
rhesu
monkey
experiment
design
makona
strain
outbreak
ebola
viru
scientif
report
doi
tkmebolaguinea
drug
trial
outcom
collabor
effort
tekmira
canadian
compani
oxford
univers
unfortun
clinic
trial
halt
recent
therapeut
benefit
patient
observ
reach
predefin
endpoint
henc
need
design
computeraid
subunit
vaccin
sirnabas
therapi
evd
fortun
genom
five
ebolavirus
sequenc
annot
thu
possibl
develop
comput
approach
design
potenti
therapi
ebola
viru
studi
aim
creat
webbas
resourc
provid
inform
requir
develop
effect
drug
vaccin
viru
sequenc
genom
download
protein
mrna
sequenc
five
ebolavirus
bundibugyo
ebolaviru
bdbv
access
number
reston
ebolaviru
restv
strain
pennsylvania
access
number
sudan
ebolaviru
sudv
strain
gulu
access
number
tai
forest
ebolaviru
tafv
access
number
ebola
viru
mayinga
zair
ebovmay
access
number
ncbi
genom
size
kb
gc
content
seven
gene
present
ebov
two
variant
glycoprotein
gp
gene
restv
sudv
three
splice
variant
annot
speci
follow
splice
variant
gp
gp
spike
protein
ii
sgp
solubl
gp
default
variant
iii
ssgp
small
solubl
gp
variant
align
file
proteinmrna
across
differ
speci
gener
use
clustalw
viralspecif
conserv
pattern
order
investig
virusspecif
conserv
pattern
overlap
pattern
amino
acid
gener
protein
abovement
five
ebolavirus
protein
total
includ
differ
splice
variant
gp
gene
five
ebolavirus
possibl
peptid
protein
predict
immunolog
potenti
one
challeng
vaccin
develop
avoid
selftoler
bodi
immun
system
rare
act
selfantigen
thu
avail
human
bodi
human
genom
remov
order
achiev
goal
remov
viral
pattern
ident
pattern
found
human
thousand
proteom
human
thousand
proteom
creat
use
genom
data
translat
protein
sequenc
led
us
peptidepattern
found
viru
absent
human
proteom
order
develop
effect
vaccin
wide
rang
speci
import
identifi
conserv
pattern
across
differ
speci
ebola
therefor
studi
involv
identif
uniqu
pattern
peptid
along
frequenc
occurr
across
differ
ebolavirus
also
high
prioriti
given
pattern
common
number
ebolavirus
led
patternspeptid
size
residu
conserv
among
ebolavirus
pipelin
epitop
predict
explor
peptid
found
conserv
differ
ebolavirus
absent
human
proteom
next
goal
identifi
peptid
could
activ
human
immun
system
order
gener
memori
cell
ebola
viru
order
understand
immunomodulatori
stimulatori
effect
peptid
comput
differ
type
epitop
describ
bcell
epitop
predict
studi
use
recent
develop
method
lbtope
predict
linear
bcell
epitop
among
aforement
conserv
pattern
lbtope
highli
accur
method
train
larg
dataset
contain
experiment
valid
bcell
epitop
nonepitop
appli
lbtope
model
default
threshold
probabl
cutoff
similarli
conform
bcell
epitop
predict
conserv
peptid
use
cbtope
cbtope
uniqu
method
predict
conform
bcell
epitop
antigen
amino
acid
sequenc
oppos
previou
method
requir
structur
antigen
predict
cbtope
result
obtain
default
threshold
cutoff
implement
websit
mhc
allel
bind
peptid
major
histocompat
complex
mhc
set
cell
surfac
molecul
play
vital
role
human
immun
system
major
role
mhc
bind
antigen
region
peptid
present
peptid
cell
surfac
appropri
tcell
recogn
peptid
thu
import
predict
mhc
binder
binder
abil
activ
tcell
immun
system
studi
use
top
cutoff
default
predict
mhc
class
binder
matrixbas
program
predict
peptid
bind
potenti
mhc
class
allel
binder
may
activ
cytotox
tlymphocyt
ctl
may
call
binder
potenti
ctl
epitop
predict
use
ctlpred
default
paramet
similarli
predict
potenti
thelper
epitop
predict
mhc
class
ii
binder
conserv
peptid
predict
mhc
class
ii
binder
perform
use
propr
top
threshold
suggest
author
propr
quantitativevirtu
matrixbas
method
allow
user
predict
promiscu
mhc
class
ii
binder
allel
tcell
respons
predict
addit
predict
mhc
binder
potenti
tcell
epitop
also
predict
ctl
epitop
use
direct
method
ctlpred
ctlpred
direct
method
predict
tcell
epitop
ctl
primari
sequenc
antigen
instead
use
intermedi
step
mhc
class
binder
predict
ctlpred
number
modul
eg
ann
svm
predict
ctl
epitop
studi
use
svmbase
modul
default
paramet
past
numer
method
scientif
report
doi
develop
predict
mhc
class
ii
binder
none
abl
predict
type
interleukin
releas
binder
studi
use
method
ifnepitop
default
threshold
predict
antigen
region
mhc
binder
activ
cell
thelper
cell
type
respons
releas
interferongamma
brief
predict
induc
peptid
ebola
antigen
use
ifnepitop
similarli
also
predict
antigen
region
activ
cell
respons
releas
cytokin
studi
use
default
threshold
predict
antigen
region
peptid
ebola
antigen
order
design
sirnabas
therapeut
ebola
viru
gener
oligonucleotid
correspond
mrna
sequenc
length
suffici
silenc
cognat
mrna
target
sequenc
literatur
consid
core
length
sirna
duplex
apart
nucleotid
overhang
use
rnaibas
therapi
silenc
target
transcript
predict
method
develop
base
length
sirna
sequenc
first
gener
overlap
oligonucleotid
gene
abovement
five
ebolavirus
secondli
remov
oligonucleotid
present
human
gene
sequenc
far
use
human
refer
mrna
thirdli
identifi
oligonucleotid
conserv
differ
speci
viru
final
got
oligonucleotid
conserv
viral
speci
absent
human
genom
order
identifi
oligonucleotid
could
serv
effici
sirna
ebola
viru
predict
efficaci
oligonucleotid
sirna
use
desirm
softwar
default
paramet
final
set
subgroup
genewis
subgroup
separ
highli
potent
sirna
efficaci
greater
valu
overal
architectur
ebolavcr
develop
studi
shown
fig
tool
section
phylogenet
tree
mega
softwar
version
use
creat
phylogenet
tree
protein
sequenc
ebola
viru
order
gener
multipl
sequenc
align
protein
use
softwar
clustalw
align
use
construct
tree
use
maximumlikelihood
algorithm
branch
length
visual
given
option
protein
structur
ebola
antigen
order
understand
function
ebola
protein
predict
tertiari
structur
ebola
protein
assist
scientif
commun
predict
tertiari
structur
viral
protein
use
itass
suit
templat
structur
predict
deriv
use
hhbuilt
suit
default
paramet
predict
protein
structur
protein
except
l
protein
avail
web
resourc
visual
tool
integr
visual
structur
addit
predict
structur
also
provid
structur
ebola
viru
protein
present
protein
data
bank
pdb
believ
structur
help
computeraid
drug
design
subunit
vaccin
ebola
viru
peptid
studi
gener
possibl
overlap
peptid
ebolaviru
remov
redund
well
peptid
found
human
refer
proteom
tabl
peptid
present
genomesbas
human
proteom
also
filter
avoid
cross
present
individu
observ
peptid
restv
singl
peptid
sudv
share
human
refer
proteom
addit
also
observ
peptid
ebov
present
human
refer
proteom
present
among
peptid
genomesbas
human
proteom
proteinwis
distribut
peptid
differ
ebolavirus
shown
supplementari
file
figur
vaccin
candid
conserv
peptid
among
differ
ebolavirus
help
applic
broad
spectrum
therefor
extract
conserv
peptid
found
peptid
share
among
five
ebolavirus
studi
figur
peptid
conserv
among
four
human
pathogen
ebolavirus
exclud
restv
fig
tabl
common
peptid
share
among
differ
ebolavirus
potenti
design
vaccin
type
ebolavirus
comput
proteinwis
distribut
conserv
peptid
among
differ
speci
ebola
viru
figur
tabl
order
identifi
conserv
region
comput
multipl
sequenc
align
protein
viru
use
clustalw
figur
also
predict
immunogen
peptid
particularli
conserv
peptid
use
immunopipelin
analysi
found
conserv
peptid
bcell
epitop
promiscu
mhc
binder
peptid
common
among
four
human
pathogen
ebolavirus
exclud
restv
pathogen
human
peptid
highli
promiscu
vaccin
candid
tabl
analyz
peptid
activ
arm
immun
system
tabl
peptid
conserv
three
speci
three
peptid
conserv
least
two
ebolavirus
sirnabas
therapi
align
mrna
sequenc
perform
multipl
sequenc
align
msa
gene
across
five
ebolavirus
order
identifi
conserv
region
differ
gene
unabl
locat
singl
oligonucleotid
common
five
ebolavirus
got
stretch
maximum
length
nine
nucleotid
across
five
ebolavirus
studi
use
clustalw
softwar
msa
jalview
visual
align
figur
potenti
sirna
suppressor
specif
oligonucleotid
gener
five
ebolavirus
figur
show
architectur
ebola
rnai
pipelin
present
strategi
adopt
identifi
potenti
therapeut
sirna
first
comput
efficaci
oligonucleotid
use
desirm
softwar
default
threshold
valu
next
identifi
present
human
genom
order
elimin
offtarget
interact
final
select
sirna
may
silenc
target
gene
efficaci
valu
want
identifi
promiscu
sirna
could
target
five
ebolavirus
unfortun
find
singl
common
oligonucleotid
five
ebolavirus
figur
distribut
sirna
select
ebola
across
five
ebolavirus
gene
level
shown
fig
distribut
potenti
sirna
target
gene
ebolavirus
shown
tabl
number
sirna
target
common
ebolavirus
enlist
supplementari
tabl
server
show
potenti
sirna
target
gene
form
tabl
circo
plot
visual
user
get
detail
inform
like
strain
id
gene
sirna
sequenc
cognat
mrna
sequenc
start
posit
efficaci
websit
user
sort
tabl
accord
posit
efficaci
get
efficaci
sirna
along
detail
detail
genewis
distribut
sirna
differ
ebolavirus
shown
supplementari
file
figur
webbas
platform
integr
number
comput
tool
provid
comprehens
servic
scientif
commun
work
ebola
viru
tool
use
design
therapeut
new
ebolaviru
drug
resist
ebolaviru
follow
brief
descript
modul
integr
ebolavcr
map
experiment
valid
epitop
immun
epitop
databas
iedb
largest
databas
experiment
character
antigen
region
epitop
may
modul
immun
system
summari
iedb
maintain
experiment
valid
epitop
order
identifi
antigen
region
alreadi
characteris
past
map
experiment
proven
iedb
epitop
ebola
antigen
extract
epitop
use
filter
sourc
organ
ebolaviru
name
ebolaviru
link
epitop
sourc
organ
origin
sourc
page
iedb
sourc
molecul
predict
id
immun
statu
tabl
list
potenti
peptid
epitop
activ
arm
immun
system
epitop
link
ncbi
detail
descript
also
provid
facil
map
peptid
user
sequenc
iedb
mhcbn
bcipep
databas
phylogenet
tree
import
understand
similar
among
ebolavirus
evolut
speci
order
understand
evolut
ebolaviru
gener
phylogenet
tree
base
similar
protein
sequenc
studi
mega
softwar
use
gener
phylogenet
tree
use
default
paramet
tree
avail
web
resourc
analysi
phylogenet
tree
gene
observ
evolut
ebolavirus
found
restv
sudv
coevolv
phylogenet
node
bdbv
tafv
close
relat
ebov
evolv
distant
node
ancestri
promis
vaccin
epitop
vaccin
ebola
viru
need
hour
studi
made
attempt
analyz
conserv
epitop
result
vaccin
cover
broad
rang
speci
sequenc
till
date
besid
conserv
immun
respons
next
challeng
address
vaccin
candid
predict
divers
kind
immun
respons
better
efficaci
candid
past
comput
studi
carri
design
vaccin
virus
studi
limit
term
number
protein
cover
type
immun
respons
consid
observ
peptid
capabl
stimul
differ
kind
immun
current
studi
uncov
conserv
peptid
among
human
pathogen
ebolaviru
activ
cytotox
lymphocyt
ctl
addit
ctl
activ
also
identifi
peptid
activ
helper
respons
bind
mhc
class
ii
also
elimin
peptid
could
share
sequenc
ident
human
proteom
avoid
crossreact
vaccin
candid
human
protein
hope
vaccin
candid
provid
better
immun
lead
success
vaccin
futur
also
discov
conserv
peptid
abl
trigger
bcell
respons
gener
antibodi
among
human
pathogen
subtyp
ebola
viru
peptid
could
serv
diagnosi
ebola
viru
also
examin
experiment
valid
epitop
avail
immun
epitop
databas
iedb
observ
epitop
cover
studi
peptid
avail
iedb
demonstr
valid
predict
addit
suggest
epitop
studi
one
valid
experiment
bind
mhc
allel
hla
hlab
peptid
ipvyqvnnl
identifi
submit
iedb
http
kent
j
weinhold
georgia
tomara
yongt
cai
kelli
plonk
scott
pruitt
smita
k
nair
sirna
therapi
potenti
sirna
everi
gene
report
studi
predict
efficaci
exclus
sirna
gene
known
ebolavirus
found
none
sirna
present
five
ebolavirus
sirna
share
two
speci
sirna
share
three
speci
bdbv
ebov
restv
studi
use
publish
sirna
efficaci
predictor
name
desirm
develop
group
one
may
question
use
desirm
softwar
larg
number
exist
softwar
packag
predict
efficaci
sirna
avail
use
standalon
version
allow
us
analyz
larg
number
oligonucleotid
algorithm
shown
compar
perform
method
thu
select
pure
base
avail
criteria
like
perform
studi
almost
softwar
use
predict
potenti
candid
vaccin
sirna
therapeut
develop
group
extens
use
softwar
eg
propr
ctlpred
develop
laboratori
softwar
packag
uniqu
avail
group
like
ifnepitop
conclus
tri
best
use
appropri
softwar
packag
gener
resourc
